Background:
Multimodal imaging plays a crucial role in
evaluating suspected cardiac tumours. In recent years, three-dimensional (3D)
printing technology has continued to advance such that image-based 3D-printed
models have been incorporated into the auxiliary diagnosis and treatment of
cardiac tumour diseases. The purpose of this review is to analyze the existing
literature on the application of 3D printing in cardiac tumour surgery to examine
the current status of the application of this technology.
Methods:
By searching PubMed, Cochrane, Scopus and Google Scholar, as
well as other resource databases, a completed review of the available literature
was performed. Effect sizes from published studies were investigated, and results
are presented concerning the use of 3D surgical planning in the management of
cardiac tumours.
Results:
According to the reviewed literature,
our study comes to the point that 3D printing is a valuable technique for
planning surgery for cardiac tumours. As shown in the review report, Mucinous and
sarcomatous tumours are the most commonly used tumours for 3D printing, magnetic
resonance imaging (MRI) and computed tomography (CT) are the most commonly used
technologies for preparing 3D printing models, the main printing technology is
stereolithography, and the most used 3D modeling software is Mimics. The printing
time and cost required for 3D printing are affected by factors such as the size
of the type, complexity, the printed material and the 3D printing technology
used. The reported research shows that 3D printing can understand the anatomy of
complex tumour cases, virtual surgical simulation, as well as facilitate
doctor-patient communication and clinical teaching.
Conclusions:
These results show that the development of 3D printing technology has brought
more accurate and safe perioperative treatment options for patients with cardiac
tumours. Therefore, 3D printing technology is expected to become a routine
clinical diagnosis and treatment tool for cardiac tumours.